Trialect

Active

The Maastricht Diabetes Study: A Population-based cohort study

Maastricht University

Host: Maastricht UMC+ and School for Cardiovascular Diseases (CARIM), The Netherlands

Main Areas of Interest

The Maastricht Study is an extensive phenotyping study that focuses on the etiology of type 2 diabetes, its classic complications (cardiovascular disease, nephropathy, neuropathy and retinopathy), and its emerging comorbidities, including cognitive decline, depression, and gastrointestinal, respiratory and musculoskeletal diseases. The study uses advanced state-of-the-art imaging techniques and extensive biobanking to determine health status in a population-based cohort of 10,000 individuals that is enriched with type 2 diabetes participants. The Maastricht Study is expected to become one of the most extensive phenotyping studies in both the general population and type 2 diabetes participants world-wide. A detailed description of the study design can be found in Schram et al, Eur J Epid 2014. (for references see: https://www.ncbi.nlm.nih.gov/pubmed/?term=The+Maastricht+Study%5BTitle%5D )

Techniques You Will Learn

The focus of the current fellowship will be on macrovascular function (e.g. carotid IMT, pulse wave velocity, carotid/brachial/femoral distensibility, ankle-brachial index) or microvascular function (e.g. central retinal microvascular diameters, flicker light-induced retinal arteriolar/venular reactivity, skin heat-induced hyperemia (LDF)). Using multivariable regression analyses, the independent association of macro- or microvascular function with disease biomarker(s) / risk factors / outcomes will be studied. Prior to the start of the fellowship, the specific topic of interest will be established with the fellow.

Curriculum

12 weeks curriculum

Fellows will be supported to settle down into their new environment (find appropriate accommodation, locate amenities, etc.). A desk space will be allocated. Full induction (safety, GCP, personal welfare, etc.) will be provided by the University’s designated staff. We will arrange an initial meeting with the fellow to discuss the objectives of the training.

The fellow will be fully trained to the activities of the study center. They will be able to engage with me (supervisor) and other members of the group in epidemiological concepts. They will also be engaged in clinical research. Prior to the training, I will discuss with the fellow his/her plans to prepare and publish their clinical work, which will require a request for a dataset (costs €20,000).

The fellow will be given opportunity to partake in group meetings and other academic activities within the department and School and the University, including attending workshops, conferences, etc. They will also be encouraged to present their work orally at a group meeting at least once before they complete their visit.

All throughout the training any peculiar challenges or specific requests of a fellow will be fully considered to ensure a responsive, relevant and adequate training plan is developed for them.

Accommodation

University welcome service and guest houses/accommodation

All information is available at the website of Maastricht University’s official housing company:

https://www.maastrichthousing.nl/

Try airbnb.com

Fees and Program Logistics

This program has the following durations available:

Duration	Fee

Who Can Apply

Host Details

Host Name: Prof. Coen D.A. Stehouwer

Affiliation: Maastricht University

Address: Maastricht UMC+, The Netherlands

Website URL: https://www.demaastrichtstudie.nl/

Disclaimer:It is mandatory that all applicants carry workplace liability insurance, e.g., https://www.protrip-world-liability.com (Erasmus students use this package and typically costs around 5 € per month - please check) in addition to health insurance when you join any of the onsite Trialect partnered fellowships.

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.